Please find enclosed the Standalone Unaudited Financial results for the Quarter ended 30th June, 2025 along with the Limited Review Report of the Statutory Auditors as approved by the Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMC Speciality Hospitals (India) Ltd reported its Q1 FY26 (quarter ended June 30, 2025) standalone unaudited results, approved by the Board on August 13, 2025. Revenue from operations grew to Rs. 6,655.29 lakhs from Rs. 5,306.80 lakhs in Q1 FY25, a jump of about 25%. Total income stood at Rs. 6,735.34 lakhs versus Rs. 5,368.89 lakhs YoY. Profit after tax rose to Rs. 736.67 lakhs from Rs. 543.18 lakhs, up roughly 36%, with basic and diluted EPS at Rs. 0.46 (vs Rs. 0.34 YoY). Deloitte Haskins & Sells issued an unmodified (clean) limited review report with no qualifications.
Strong double-digit growth in both revenue and profit signals healthy operational momentum for shareholders; a clean auditor report with no caveats reinforces confidence in the numbers.